Exactech receives $737M offer from TPG Capital to purchase the company: 3 notes

Spinal Tech

TPG Capital offered Exactech $737 million to buy the medical device company, an increase to its initial offer in October, according to Reuters.

Here are three notes:


1. The $49.25 per share offer from TPG Capital is a 17.3 percent increase to its $42 per share offer in October.


2. Exatech's board agreed to the amended terms and expects to close the all-cash deal during the first quarter of 2018.


3. When the deal was announced Oct. 23, Exatech's stock has hovered at $42. However, on Monday, Dec. 4, the company's stock was trading at $49.25.


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers